Evaluation of an Intranasal Virosomal Vaccine against Respiratory Syncytial Virus in Mice: Effect of TLR2 and NOD2 Ligands on Induction of Systemic and Mucosal Immune Responses

INTRODUCTION: RSV infection remains a serious threat to newborns and the elderly. Currently, there is no vaccine available to prevent RSV infection. A mucosal RSV vaccine would be attractive as it could induce mucosal as well as systemic antibodies, capable of protecting both the upper and lower res...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafique, Muhammad, Meijerhof, Tjarko, Wilschut, Jan, de Haan, Aalzen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620164/
https://www.ncbi.nlm.nih.gov/pubmed/23593453
http://dx.doi.org/10.1371/journal.pone.0061287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620164/
https://www.ncbi.nlm.nih.gov/pubmed/23593453
http://dx.doi.org/10.1371/journal.pone.0061287

Ejemplares similares